A. Molinari
Molecular Biology · International Journal of Nanomedicine · 2002–2015
A researcher in the Science corpus: 3 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 21 citations into it
- Biomaterials — 12 citations into it
- Biomedical Engineering — 11 citations into it
Whom A. Molinari trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from A. Molinari's perspective
Ordered by how strongly the researchers A. Molinari trusts endorse each paper. Same corpus, a different order for every researcher.
- The origins and the future of microfluidics (Nature)
- Openings between defective endothelial cells explain tumor vessel leakiness. (American Journal of Pathology)
- Pegylation: a novel process for modifying pharmacokinetics. (Clinical Pharmacokinetics)
- Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming (Nature Medicine)
- THE BIG PICTURE ON SMALL MEDICINE: THE STATE OF NANOMEDICINE PRODUCTS APPROVED FOR USE OR IN CLINICAL TRIALS (Nanomedicine: Nanotechnology, Biology and Medicine)
- Tumor delivery of macromolecular drugs based on the EPR effect. (Advanced Drug Delivery Reviews)
- Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy (International Journal of Nanomedicine)
- Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential (International Journal of Nanomedicine)
- Liposome Technology for Industrial Purposes (Journal of Drug Delivery)
- Preparation, Characterization and Applications of Liposomes: State of the Art
Their papers
- Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells* (2009) — 1,413 citations
- Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles (2002) — 792 citations
- Liposomes as nanomedical devices (2015) — 1,744 citations